Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.
Clinical trial NCT06255626 · RECRUITING
Trial details
- NCT number
- NCT06255626
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-27
- Primary completion
- 2025-09-01
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.